Surgery may improve survival in metastatic breast cancer

04/1/2013 | U.S. News & World Report

A German study found patients with metastatic breast cancer who underwent surgery to remove lung tumors had an average survival rate of 103 months in cases of complete removal, and 20 to 23 months in those whose tumors could not be completely removed. The results suggest physicians should consider surgery in such patients, researchers wrote in The Annals of Thoracic Surgery.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA